- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-9378
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers ; volume:4 ; number:2 ; day:17 ; month:6 ; year:2009 ; pages:1 ; date:6.2009
Infectious agents and cancer ; 4, Heft 2 (17.6.2009), 1, 6.2009
- Creator
-
Bhatt, A.
- Contributor
-
Bhende, P.
Damania, B.
SpringerLink (Online service)
- DOI
-
10.1186/1750-9378-4-S2-O7
- URN
-
urn:nbn:de:1111-2016072622758
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bhatt, A.
- Bhende, P.
- Damania, B.
- SpringerLink (Online service)
Other Objects (12)
Metabolic reprogramming and metabolic sensors in KSHV-induced cancers and KSHV infection
FGFR2 Promotes Gastric Cancer Progression by Inhibiting the Expression of Thrombospondin4 via PI3K-Akt-Mtor Pathway
Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia
Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia
The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses
Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
Multiple outcomes for PI3K/Akt/mTOR targeting in non-Hodgkin lymphoma
Targeting the Hedgehog and PI3K/AKT/mTOR signaling pathways in rhabdomyosarcoma
Angelica Sinensis promotes myotube hypertrophy through the PI3K/Akt/mTOR pathway
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
SH2B1 promotes NSCLC cell proliferation through PI3K/Akt/mTOR signaling cascade
Nascent proteome analysis of MAPK and PI3K-AKT-mTOR oncogenic signaling pathways
Metabolic reprogramming and metabolic sensors in KSHV-induced cancers and KSHV infection
FGFR2 Promotes Gastric Cancer Progression by Inhibiting the Expression of Thrombospondin4 via PI3K-Akt-Mtor Pathway
Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia
Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia
The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses
Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
Multiple outcomes for PI3K/Akt/mTOR targeting in non-Hodgkin lymphoma
Targeting the Hedgehog and PI3K/AKT/mTOR signaling pathways in rhabdomyosarcoma
Angelica Sinensis promotes myotube hypertrophy through the PI3K/Akt/mTOR pathway
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
SH2B1 promotes NSCLC cell proliferation through PI3K/Akt/mTOR signaling cascade
Nascent proteome analysis of MAPK and PI3K-AKT-mTOR oncogenic signaling pathways
Metabolic reprogramming and metabolic sensors in KSHV-induced cancers and KSHV infection
FGFR2 Promotes Gastric Cancer Progression by Inhibiting the Expression of Thrombospondin4 via PI3K-Akt-Mtor Pathway
Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia
Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia
The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses
Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
Multiple outcomes for PI3K/Akt/mTOR targeting in non-Hodgkin lymphoma
Targeting the Hedgehog and PI3K/AKT/mTOR signaling pathways in rhabdomyosarcoma
Angelica Sinensis promotes myotube hypertrophy through the PI3K/Akt/mTOR pathway
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
SH2B1 promotes NSCLC cell proliferation through PI3K/Akt/mTOR signaling cascade